{"id": "1385133757854883844", "creation": 1619076597.0, "user_id": "98651557", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 18, "reply_count": 2, "like_count": 39, "quote_count": 3}}, "text": "CEO @ThomasLingelba1 comments on the initiation of the pivotal Phase 3 clinical trial for Valneva's inactivated, adjuvanted #COVID19 #vaccine candidate, VLA2001\nhttps://t.co/k1s1ELvbl3 https://t.co/GQefNrjJiJ", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE"]}